Your search for "anero 4" return 28 results.
Ceva consolidates its position as the leading French player in the global animal health market >
Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market
CVM and Ceva Enter Educational Partnership for Latin American Veterinarians >
The NC State College of Veterinary Medicine and animal health company Ceva are collaborating on a distance learning project in Latin America.
Ceva honours rare livestock breeds during the French National Prize for Animal Agro biodiversity Awards ceremony >
The Fondation du Patrimoine and Ceva Santé Animale awarded the “Fondation du Patrimoine National Animal Agro-Biodiversity Prize” to 3 associations committed to preserving regional livestock breed, dur...
Ceva Santé Animale given European Commission go ahead to acquire Merial assets from Boehringer Ingelheim >
The European Commission recently gave its approval for the transfer to Ceva Santé Animale of nine products developed and currently marketed by Merial.
Ceva acquires Biovac, leading French manufacturer of Autogenous vaccines >
Move will reinforce group’s AMR strategy to find alternative solutions to use of antibiotics
Ceva’s new generation Vectormune® AI vaccine proves to be a useful tool to control HPAI >
A paper* recently published in the peer-reviewed journal Vaccine** reports that Ceva’s new generation vaccine, Vectormune® AI, offers significant advantages over previously available vaccines against...
Feeding the world : meat, milk and eggs for all >
By 2050, global consumption of meat will double: most of the increased demand will be for chicken in developing countries. Today, 1 in every 4 broiler chickens produced is protected by Ceva’s new gene...
Reducing the threat farm animals pose to global public health >
Half of all infectious diseases and 3/4 of newly emerging diseases that affect people are zoonotic - transmitted to people from animals. Ceva is working with partners throughout the world to reduce th...
Tildren® receives FDA approval to control clinical signs of Navicular Syndrome >
Tildren® is now available in the US
Egypt study confirms that a single rHVT-H5 hatchery vaccination could be an effective tool to address A/H5N1 prevention >
Research confirms that in endemic countries the classical inactivated vaccines are less effective and hard to administer, while application of a rHVT vector hatchery vaccine is labour saving, cost eff...